动态增强MRI影像组学特征预测肿块型肝内胆管癌微血管侵犯
研究纳入126例手术切除的单发肿块型肝内胆管癌患者(MVI阳性34例、阴性92例),按7:3分为训练集与验证集,基于DCE-MRI可重复特征以LASSO回归构建影像组学特征。较大肿瘤尺寸和较高影像组学评分与MVI正相关,由7个小波特征组成的影像组学特征在训练集AUC=0.873、验证集AUC=0.850。
要点
- 影像组学特征由7个小波特征组成,训练集AUC=0.873、验证集AUC=0.850。
- 较大肿瘤尺寸与MVI正相关(训练集p<0.001,验证集p=0.008)。
- 较高影像组学评分与MVI正相关(训练集p<0.001,验证集p=0.001)。
关键影像表现/征象
- 较大肿瘤尺寸与MVI正相关(训练集p<0.001,验证集p=0.008)。
- 较高影像组学评分与MVI正相关(训练集p<0.001,验证集p=0.001)。
诊断标准与关键数值
- 影像组学特征由7个小波特征组成,训练集预测MVI的AUC=0.873。
- 影像组学特征在验证集预测MVI的AUC=0.850。
临床应用与阅片要点
- 基于DCE-MRI的影像组学特征可用于术前预测IMCC的MVI,可能有助于制定治疗策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To develop a radiomics signature based on dynamic contrast-enhanced (DCE) MR images for preoperative prediction of microvascular invasion (MVI) in patients with mass-forming intrahepatic cholangiocarcinoma (IMCC).
METHODS: One hundred twenty-six patients with surgically resected single IMCC (34 MVI-positive and 92 MVI-negative) were enrolled and allocated to training and validation cohorts (7:3 ratio). Findings of clinical characteristics and MR features were analyzed. A radiomics signature was built on the basis of reproducible features by using the least absolute shrinkage and selection operator (LASSO) regression algorithm in the training cohort. The prediction performance of radiomics signature was evaluated by receiver operating characteristics curve (ROC) analysis. Internal validation was performed on an independent cohort containing 38 patients.
RESULTS: Larger tumor size and higher radiomics score were positively correlated with MVI in both training cohort (p < 0.001, < 0.001, respectively) and validation cohort (p = 0.008, 0.001, respectively). The radiomics signature, consisting of seven wavelet features, showed optimal prediction performance in both training (AUC = 0.873) and validation cohorts (AUC = 0.850).
CONCLUSION: A radiomics signature derived from DCE-MRI of the liver can be a reliable imaging biomarker for predicting MVI of IMCC, which could aid in tailoring treatment strategies.
KEY POINTS: • The radiomics signature based on dynamic contrast-enhanced magnetic resonance imaging can be a useful tool to preoperatively predict MVI of IMCC. • Larger tumor size is positively correlated with MVI of IMCC.
引用
- Zhou Y, Zhou G, Zhang J, et al. Radiomics signature on dynamic contrast-enhanced MR images: a potential imaging biomarker for prediction of microvascular invasion in mass-forming intrahepatic cholangiocarcinoma. Eur Radiol. 2021. PMID: 33638019. doi:10.1007/s00330-021-07793-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。